(Q37621256)

21 August 2017

1 reference

title

Histone deacetylases and the immunological network: implications in cancer and inflammation (English)

1 reference

21 August 2017

0 references

A Villagra

1

1 reference

21 August 2017

E M Sotomayor

series ordinal

2

1 reference

21 August 2017

E Seto

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

26 October 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

29

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

157-173

1 reference

Histone deacetylation : an attractive target for cancer therapy?

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Regulation of Th2 differentiation and Il4 locus accessibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

miRNA regulation of cytokine genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Epigenetics and T helper 1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Molecular mechanisms and cellular effects of glucocorticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Identification of mouse histone deacetylase 1 as a growth factor-inducible gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Control of cytokine gene transcription in Th1 and Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

T-bet dependent removal of Sin3A-histone deacetylase complexes at the Ifng locus drives Th1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Duration of nuclear NF-kappaB action regulated by reversible acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Trichostatin A attenuates airway inflammation in mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Cytokine function: a study in biologic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The interplay between innate and adaptive immunity regulates cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Role of RUNX family members in transcriptional repression and gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The function of E- and Id proteins in lymphocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Recent progress in the biology and physiology of sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Epigenetic consequences of AML1-ETO action at the human c-FMS locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Enhancing the apoptotic and therapeutic effects of HDAC inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Acetylation and deacetylation of non-histone proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Tumour necrosis factor-alpha depletes histone deacetylase 1 protein through IKK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

MS-275, a potent orally available inhibitor of histone deacetylases--the development of an anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

HDAC6 is a microtubule-associated deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The Stat family in cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase regulation of immune gene expression in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Requirement of histone deacetylase activity for signaling by STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Acetylation of Stat1 modulates NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

A phosphorylation-acetylation switch regulates STAT1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Valproic acid for the treatment of myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Differentiation of erythroleukemic cells in the presence of inhibitors of DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Interleukin-12 p40 promoter activity is regulated by the reversible acetylation mediated by HDAC1 and p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Discrete roles for histone acetylation in human T helper 1 cell-specific gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase 8 in neuroblastoma tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase 3 associates with and represses the transcription factor GATA-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The role of histone deacetylases in asthma and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Stat protein transactivation domains recruit p300/CBP through widely divergent sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Microarray-based classification of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase inhibitors in lymphoma and solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Variations on a theme: the alternate translocations in APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Caspase-8 cleaves histone deacetylase 7 and abolishes its transcription repressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Mammalian microRNAs: a small world for fine-tuning gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Dimerization: a versatile switch for oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Perspective: machines for RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylation inhibits IL4 gene expression in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Stat3 dimerization regulated by reversible acetylation of a single lysine residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

HDAC6 expression is correlated with better survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Long-range histone acetylation of the Ifng gene is an essential feature of T cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The changing face of HDAC inhibitor depsipeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone Deacetylase 1/mSin3A Disrupts Gamma Interferon-Induced CIITA Function and Major Histocompatibility Complex Class II Enhanceosome Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

SIRT1 longevity factor suppresses NF-κB -driven immune responses: regulation of aging via NF-κB acetylation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Evaluation of multiple biologic parameters in cervical carcinoma: high macrophage infiltration in HPV-associated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

When Sirtuins and NF-κB Collide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Role of altered expression of HLA class I molecules in cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Recent advances in the understanding of interleukin-2 signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Histone hyperacetylation is associated with amelioration of experimental colitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Depletion of histone deacetylase protein: a common consequence of inflammatory cytokine signaling?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Cis elements for transporter associated with antigen-processing-2 transcription: two new promoters and an essential role of the IFN response factor binding element in IFN-gamma-mediated activation of the transcription initiator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Rapid histone deacetylation and transient HDAC association in the IL-2 promoter region of TSST-1-stimulated T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Interleukin-8: a very important chemokine of the human airway epithelium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.334

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.334

1 reference

21 August 2017

1 reference